Chapter 3: Utilization of comprehensive geriatric assessment (CGA) in healthcare and caregiving settings by related professionals: English translation of the Japanese CGA-based healthcare guidelines 2024

IF 2.4 4区医学 Q3 GERIATRICS & GERONTOLOGY

Geriatrics & Gerontology International Pub Date : 2025-03-16 DOI:10.1111/ggi.15088

Yuko Takeshita, Yasushi Takeya, Fumihiro Mizokami, Satoru Ebihara, Yukari Tsubata, Masahiro Akishita

{"title":"Chapter 3: Utilization of comprehensive geriatric assessment (CGA) in healthcare and caregiving settings by related professionals: English translation of the Japanese CGA-based healthcare guidelines 2024","authors":"Yuko Takeshita, Yasushi Takeya, Fumihiro Mizokami, Satoru Ebihara, Yukari Tsubata, Masahiro Akishita","doi":"10.1111/ggi.15088","DOIUrl":null,"url":null,"abstract":"Is comprehensive geriatric assessment (CGA) effective in nursing (nursing department) older adults?Is CGA effective for the provision of care for older adults by care workers (e.g., care managers and certified care workers)?Is the use of CGA effective for medication management in older adults?Is the use of CGA by pharmacists effective for performing medication reviews in older adults?Is CGA effective for the rehabilitation of older adults?Is CGA effective for ACP in older adults with comorbid malignancies or a history of malignancy?YT received lecture fees from Astellas Pharma, Daiichi Sankyo, and Merck & Co. YT received research funding from Ono Pharmaceutical and Pfizer Health Research Foundation, as well as lecture fees from AstraZeneca, Bristol-Myers Squibb, Chugai Pharmaceutical, Daiichi Sankyo, Kyowa Kirin, Taiho Pharmaceutical, and Takeda. MA received research funding from Astellas Pharma, Bayer Yakuhin, Chugai Pharmaceutical Co., Daiichi Sankyo, Eisai, Merck & Co., Fukuda Lifetech, Mitsubishi-Tanabe Pharma, Ono Pharmaceutical, Takeda, and Tsumura as well as lecture fees from Daiichi Sankyo, Merck & Co., Toa Eiyo, and Towa Pharmaceutical. All other authors declare no conflict of interest.","PeriodicalId":12546,"journal":{"name":"Geriatrics & Gerontology International","volume":"25 S1","pages":"24-29"},"PeriodicalIF":2.4000,"publicationDate":"2025-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ggi.15088","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Geriatrics & Gerontology International","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ggi.15088","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Is comprehensive geriatric assessment (CGA) effective in nursing (nursing department) older adults?

Is CGA effective for the provision of care for older adults by care workers (e.g., care managers and certified care workers)?

Is the use of CGA effective for medication management in older adults?

Is the use of CGA by pharmacists effective for performing medication reviews in older adults?

Is CGA effective for the rehabilitation of older adults?

Is CGA effective for ACP in older adults with comorbid malignancies or a history of malignancy?

YT received lecture fees from Astellas Pharma, Daiichi Sankyo, and Merck & Co. YT received research funding from Ono Pharmaceutical and Pfizer Health Research Foundation, as well as lecture fees from AstraZeneca, Bristol-Myers Squibb, Chugai Pharmaceutical, Daiichi Sankyo, Kyowa Kirin, Taiho Pharmaceutical, and Takeda. MA received research funding from Astellas Pharma, Bayer Yakuhin, Chugai Pharmaceutical Co., Daiichi Sankyo, Eisai, Merck & Co., Fukuda Lifetech, Mitsubishi-Tanabe Pharma, Ono Pharmaceutical, Takeda, and Tsumura as well as lecture fees from Daiichi Sankyo, Merck & Co., Toa Eiyo, and Towa Pharmaceutical. All other authors declare no conflict of interest.

Abstract Image

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Geriatrics & Gerontology International 医学-老年医学

CiteScore

5.50

自引率

6.10%

发文量

189

审稿时长

4-8 weeks

期刊介绍： Geriatrics & Gerontology International is the official Journal of the Japan Geriatrics Society, reflecting the growing importance of the subject area in developed economies and their particular significance to a country like Japan with a large aging population. Geriatrics & Gerontology International is now an international publication with contributions from around the world and published four times per year.